Hendrik Jan Houthoff

This inventor holds 8 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Kreatech Diagnostics, Linxis B.v., Kreatech Biotechnology B.v.. Active years: 1998-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hendrik Jan Houthoff. Retrieved from https://idiyas.com/inventor/hendrik-jan-houthoff

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 3)

% Patents Active = 87.5

EPO Patents = 2 (Patent Applications = 7)

Average Co-Inventor Count = 4.8

ph-index = 4

Forward Citations = 178(Granted Patents)

Company Filing History:

Kreatech Biotechnology B.v.

patents

Years Active: 1998-2026

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12552866 - INTERNALIZING BINDING MOLECULES TARGETING RECEPTORS INVOLVED IN CELL PROLIFERATION OR IN CELL DIFFERENTIATION (2026-02-17),

2. 10668168 - Method for removing weakly bound functional moieties from cell targeting conjugates (2020-06-02),

3. 10668162 - Method for preparing cell targeting conjugates, and the complexes obtained (2020-06-02),

4. 6416962 - Method and device for identifying a mycobacterium species responsible for a mycobacterial infection (2002-07-09),

5. 6133038 - Platinum-containing compounds methods for their preparation and (2000-10-17),

6. 5985566 - Platinum-containing compounds, methods for their preparation and (1999-11-16),

7. 5817473 - Method and device for identifying a mycobacterium species responsible (1998-10-06),

8. 5714327 - Platinum-containing compounds, methods for their preparation and (1998-02-03),

Title: Hendrik Jan Houthoff: Innovator in Cell-Targeting Conjugates

Introduction

Hendrik Jan Houthoff is a prominent inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the development of cell-targeting conjugates. With a total of 8 patents to his name, Houthoff's work has the potential to impact therapeutic and diagnostic applications.

Latest Patents

Houthoff's latest patents include innovative methods for preparing cell-targeting conjugates. One of his notable inventions is a method for preparing these conjugates by coupling functional moieties, such as therapeutic compounds or diagnostic agents, to targeting moieties. This method not only enhances the efficacy of the conjugates but also leads to the development of pharmaceutical compositions that incorporate these innovative compounds. Another significant patent focuses on a method for removing weakly bound functional moieties from cell-targeting conjugates, resulting in more stable formulations. This advancement is crucial for the creation of reliable pharmaceutical compositions that can be used as medicaments.

Career Highlights

Throughout his career, Houthoff has worked with notable companies such as Kreatech Diagnostics and Kreatech Biotechnology B.V. His experience in these organizations has allowed him to refine his expertise in biotechnology and contribute to groundbreaking research in the field.

Collaborations

Houthoff has collaborated with esteemed colleagues, including Remco Maria Van Es and Jan Reedijk. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Hendrik Jan Houthoff is a distinguished inventor whose work in cell-targeting conjugates is paving the way for advancements in medical treatments. His innovative patents and collaborations highlight his commitment to improving therapeutic and diagnostic methodologies.

Profile summary based on public USPTO records.